1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Gastroparesis Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Gastroparesis Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Drug Treatment 1.4.3 Surgical Treatment 1.5 Market by Application 1.5.1 Global Gastroparesis Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Ambulatory Surgical Center 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Gastroparesis Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Gastroparesis Treatment Industry 1.6.1.1 Gastroparesis Treatment Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Gastroparesis Treatment Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Gastroparesis Treatment Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Gastroparesis Treatment Market Perspective (2015-2026) 2.2 Gastroparesis Treatment Growth Trends by Regions 2.2.1 Gastroparesis Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Gastroparesis Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Gastroparesis Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Gastroparesis Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Gastroparesis Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Gastroparesis Treatment Players by Market Size 3.1.1 Global Top Gastroparesis Treatment Players by Revenue (2015-2020) 3.1.2 Global Gastroparesis Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Gastroparesis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Gastroparesis Treatment Market Concentration Ratio 3.2.1 Global Gastroparesis Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Gastroparesis Treatment Revenue in 2019 3.3 Gastroparesis Treatment Key Players Head office and Area Served 3.4 Key Players Gastroparesis Treatment Product Solution and Service 3.5 Date of Enter into Gastroparesis Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Gastroparesis Treatment Historic Market Size by Type (2015-2020) 4.2 Global Gastroparesis Treatment Forecasted Market Size by Type (2021-2026) 5 Gastroparesis Treatment Breakdown Data by Application (2015-2026) 5.1 Global Gastroparesis Treatment Market Size by Application (2015-2020) 5.2 Global Gastroparesis Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Gastroparesis Treatment Market Size (2015-2020) 6.2 Gastroparesis Treatment Key Players in North America (2019-2020) 6.3 North America Gastroparesis Treatment Market Size by Type (2015-2020) 6.4 North America Gastroparesis Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Gastroparesis Treatment Market Size (2015-2020) 7.2 Gastroparesis Treatment Key Players in Europe (2019-2020) 7.3 Europe Gastroparesis Treatment Market Size by Type (2015-2020) 7.4 Europe Gastroparesis Treatment Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Gastroparesis Treatment Market Size (2015-2020) 8.2 Gastroparesis Treatment Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Gastroparesis Treatment Market Size by Type (2015-2020) 8.4 Asia-Pacific Gastroparesis Treatment Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Medtronic 9.1.1 Medtronic Company Details 9.1.2 Medtronic Business Overview and Its Total Revenue 9.1.3 Medtronic Gastroparesis Treatment Introduction 9.1.4 Medtronic Revenue in Gastroparesis Treatment Business (2015-2020)) 9.1.5 Medtronic Recent Development 9.2 Abbott 9.2.1 Abbott Company Details 9.2.2 Abbott Business Overview and Its Total Revenue 9.2.3 Abbott Gastroparesis Treatment Introduction 9.2.4 Abbott Revenue in Gastroparesis Treatment Business (2015-2020) 9.2.5 Abbott Recent Development 9.3 Bausch Health 9.3.1 Bausch Health Company Details 9.3.2 Bausch Health Business Overview and Its Total Revenue 9.3.3 Bausch Health Gastroparesis Treatment Introduction 9.3.4 Bausch Health Revenue in Gastroparesis Treatment Business (2015-2020) 9.3.5 Bausch Health Recent Development 9.4 Boston Scientific 9.4.1 Boston Scientific Company Details 9.4.2 Boston Scientific Business Overview and Its Total Revenue 9.4.3 Boston Scientific Gastroparesis Treatment Introduction 9.4.4 Boston Scientific Revenue in Gastroparesis Treatment Business (2015-2020) 9.4.5 Boston Scientific Recent Development 9.5 C.R. Bard 9.5.1 C.R. Bard Company Details 9.5.2 C.R. Bard Business Overview and Its Total Revenue 9.5.3 C.R. Bard Gastroparesis Treatment Introduction 9.5.4 C.R. Bard Revenue in Gastroparesis Treatment Business (2015-2020) 9.5.5 C.R. Bard Recent Development 9.6 Johnson & Johnson 9.6.1 Johnson & Johnson Company Details 9.6.2 Johnson & Johnson Business Overview and Its Total Revenue 9.6.3 Johnson & Johnson Gastroparesis Treatment Introduction 9.6.4 Johnson & Johnson Revenue in Gastroparesis Treatment Business (2015-2020) 9.6.5 Johnson & Johnson Recent Development 9.7 Cardinal Health 9.7.1 Cardinal Health Company Details 9.7.2 Cardinal Health Business Overview and Its Total Revenue 9.7.3 Cardinal Health Gastroparesis Treatment Introduction 9.7.4 Cardinal Health Revenue in Gastroparesis Treatment Business (2015-2020) 9.7.5 Cardinal Health Recent Development 9.8 Evoke Pharma 9.8.1 Evoke Pharma Company Details 9.8.2 Evoke Pharma Business Overview and Its Total Revenue 9.8.3 Evoke Pharma Gastroparesis Treatment Introduction 9.8.4 Evoke Pharma Revenue in Gastroparesis Treatment Business (2015-2020) 9.8.5 Evoke Pharma Recent Development 9.9 Rhythm Pharmaceuticals 9.9.1 Rhythm Pharmaceuticals Company Details 9.9.2 Rhythm Pharmaceuticals Business Overview and Its Total Revenue 9.9.3 Rhythm Pharmaceuticals Gastroparesis Treatment Introduction 9.9.4 Rhythm Pharmaceuticals Revenue in Gastroparesis Treatment Business (2015-2020) 9.9.5 Rhythm Pharmaceuticals Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Gastroparesis Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Gastroparesis Treatment Revenue Table 3. Ranking of Global Top Gastroparesis Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Gastroparesis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Drug Treatment Table 6. Key Players of Surgical Treatment Table 7. COVID-19 Impact Global Market: (Four Gastroparesis Treatment Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Gastroparesis Treatment Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Gastroparesis Treatment Players to Combat Covid-19 Impact Table 12. Global Gastroparesis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Gastroparesis Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Gastroparesis Treatment Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Gastroparesis Treatment Market Share by Regions (2015-2020) Table 16. Global Gastroparesis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Gastroparesis Treatment Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Gastroparesis Treatment Market Growth Strategy Table 22. Main Points Interviewed from Key Gastroparesis Treatment Players Table 23. Global Gastroparesis Treatment Revenue by Players (2015-2020) (Million US$) Table 24. Global Gastroparesis Treatment Market Share by Players (2015-2020) Table 25. Global Top Gastroparesis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroparesis Treatment as of 2019) Table 26. Global Gastroparesis Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Gastroparesis Treatment Product Solution and Service Table 29. Date of Enter into Gastroparesis Treatment Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Gastroparesis Treatment Market Size by Type (2015-2020) (Million US$) Table 32. Global Gastroparesis Treatment Market Size Share by Type (2015-2020) Table 33. Global Gastroparesis Treatment Revenue Market Share by Type (2021-2026) Table 34. Global Gastroparesis Treatment Market Size Share by Application (2015-2020) Table 35. Global Gastroparesis Treatment Market Size by Application (2015-2020) (Million US$) Table 36. Global Gastroparesis Treatment Market Size Share by Application (2021-2026) Table 37. North America Key Players Gastroparesis Treatment Revenue (2019-2020) (Million US$) Table 38. North America Key Players Gastroparesis Treatment Market Share (2019-2020) Table 39. North America Gastroparesis Treatment Market Size by Type (2015-2020) (Million US$) Table 40. North America Gastroparesis Treatment Market Share by Type (2015-2020) Table 41. North America Gastroparesis Treatment Market Size by Application (2015-2020) (Million US$) Table 42. North America Gastroparesis Treatment Market Share by Application (2015-2020) Table 43. Europe Key Players Gastroparesis Treatment Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Gastroparesis Treatment Market Share (2019-2020) Table 45. Europe Gastroparesis Treatment Market Size by Type (2015-2020) (Million US$) Table 46. Europe Gastroparesis Treatment Market Share by Type (2015-2020) Table 47. Europe Gastroparesis Treatment Market Size by Application (2015-2020) (Million US$) Table 48. Europe Gastroparesis Treatment Market Share by Application (2015-2020) Table 49. Asia-Pacific Key Players Gastroparesis Treatment Revenue (2019-2020) (Million US$) Table 50. Asia-Pacific Key Players Gastroparesis Treatment Market Share (2019-2020) Table 51. Asia-Pacific Gastroparesis Treatment Market Size by Type (2015-2020) (Million US$) Table 52. Asia-Pacific Gastroparesis Treatment Market Share by Type (2015-2020) Table 53. Asia-Pacific Gastroparesis Treatment Market Size by Application (2015-2020) (Million US$) Table 54. Asia-Pacific Gastroparesis Treatment Market Share by Application (2015-2020) Table 55. Medtronic Company Details Table 56. Medtronic Business Overview Table 57. Medtronic Product Table 58. Medtronic Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 59. Medtronic Recent Development Table 60. Abbott Company Details Table 61. Abbott Business Overview Table 62. Abbott Product Table 63. Abbott Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 64. Abbott Recent Development Table 65. Bausch Health Company Details Table 66. Bausch Health Business Overview Table 67. Bausch Health Product Table 68. Bausch Health Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 69. Bausch Health Recent Development Table 70. Boston Scientific Company Details Table 71. Boston Scientific Business Overview Table 72. Boston Scientific Product Table 73. Boston Scientific Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 74. Boston Scientific Recent Development Table 75. C.R. Bard Company Details Table 76. C.R. Bard Business Overview Table 77. C.R. Bard Product Table 78. C.R. Bard Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 79. C.R. Bard Recent Development Table 80. Johnson & Johnson Company Details Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Product Table 83. Johnson & Johnson Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 84. Johnson & Johnson Recent Development Table 85. Cardinal Health Company Details Table 86. Cardinal Health Business Overview Table 87. Cardinal Health Product Table 88. Cardinal Health Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 89. Cardinal Health Recent Development Table 90. Evoke Pharma Business Overview Table 91. Evoke Pharma Product Table 92. Evoke Pharma Company Details Table 93. Evoke Pharma Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 94. Evoke Pharma Recent Development Table 95. Rhythm Pharmaceuticals Company Details Table 96. Rhythm Pharmaceuticals Business Overview Table 97. Rhythm Pharmaceuticals Product Table 98. Rhythm Pharmaceuticals Revenue in Gastroparesis Treatment Business (2015-2020) (Million US$) Table 99. Rhythm Pharmaceuticals Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Gastroparesis Treatment Market Share by Type: 2020 VS 2026 Figure 2. Drug Treatment Features Figure 3. Surgical Treatment Features Figure 4. Global Gastroparesis Treatment Market Share by Application: 2020 VS 2026 Figure 5. Hospital Case Studies Figure 6. Ambulatory Surgical Center Case Studies Figure 7. Others Case Studies Figure 8. Gastroparesis Treatment Report Years Considered Figure 9. Global Gastroparesis Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Gastroparesis Treatment Market Share by Regions: 2020 VS 2026 Figure 11. Global Gastroparesis Treatment Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Gastroparesis Treatment Market Share by Players in 2019 Figure 14. Global Top Gastroparesis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroparesis Treatment as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Gastroparesis Treatment Revenue in 2019 Figure 16. North America Gastroparesis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Gastroparesis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Asia-Pacific Gastroparesis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 20. Medtronic Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 21. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. Abbott Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 23. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Bausch Health Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 25. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Boston Scientific Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 27. C.R. Bard Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. C.R. Bard Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Johnson & Johnson Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 31. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Cardinal Health Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 33. Evoke Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Evoke Pharma Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 35. Rhythm Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Rhythm Pharmaceuticals Revenue Growth Rate in Gastroparesis Treatment Business (2015-2020) Figure 37. Bottom-up and Top-down Approaches for This Report Figure 38. Data Triangulation Figure 39. Key Executives Interviewed

Medtronic Abbott Bausch Health Boston Scientific C.R. Bard Johnson & Johnson Cardinal Health Evoke Pharma Rhythm Pharmaceuticals